July 31, 2025
Press releases
Latest news
July 30, 2025
Ultragenyx to Host Conference Call for Second Quarter 2025 Financial Results and Corporate Update
Read more
July 11, 2025
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
Read more
July 09, 2025
Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis
Read more
June 27, 2025
Ultragenyx Receives Breakthrough Therapy Designation for GTX-102 in Angelman Syndrome
Read more
June 03, 2025
Ultragenyx to Participate at Goldman Sachs 46th Annual Global Healthcare Conference
Read more
May 14, 2025
Ultragenyx Underscores Continued Commitment to Rare Disease Innovation with 2024 Impact Report
Read more
Displaying 1 - 10 of 10